Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplanta
Go back to Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplanta| (NASDAQ: SANA) | Delayed: 3.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.79 | 52 Week High | $ | |||
| Open | $3.79 | 52 Week Low | $ | |||
| Day High | $3.79 | P/E | N/A | |||
| Day Low | $3.79 | EPS | $ | |||
| Volume | 8,073 | |||||

